Literature DB >> 31309331

Prosthesis design influences segmental contribution to total cervical motion after cervical disc arthroplasty.

Avinash G Patwardhan1,2, Robert M Havey3.   

Abstract

INTRODUCTION: We investigated a new metric for assessing the quality of motion of the cervical segments over the arc of extension-to-flexion motion after cervical disc arthroplasty (CDA). We quantified: (1) the amount of motion contributed by individual spinal segments to the total cervical spine motion, termed segmental motion fraction, and its variation throughout the arc of extension-to-flexion motion and (2) how cervical disc arthroplasty using two distinct prosthesis designs may influence the segmental motion contributions.
MATERIALS AND METHODS: We tested 16 human C3-T1 spine specimens under physiologic loads; first intact, after CDA at C5-C6, and then at C5-C6 and C6-C7. The M6-C (Orthofix, USA) and Mobi-C (Zimmer, USA) disc prostheses were used in eight specimens each. RESULTS AND
CONCLUSIONS: The designs of the cervical disc prostheses tested significantly influenced the variation in segmental motion fraction as the spine underwent motion between the endpoints of extension and flexion. While the mean segmental motion contribution to the total cervical motion was not influenced by prosthesis design, the way the motion took place between the extension and flexion endpoints was significantly influenced. The M6-C artificial disc restored physiologic motion quality such that implanted segments continued to function in harmony with other segments of the cervical spine as measured before arthroplasty. Conversely, the Mobi-C prosthesis, while maintaining average motion contributions similar to the pre-implantation values, demonstrated large deviations in motion contribution over the extension-to-flexion arc motion in ten of 16 implanted segments. Such non-physiologic implant kinematics could cause excessive prosthesis wear and motion and stress shielding at adjacent segments. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Cervical; Cervical disc arthroplasty; Quality of motion; Segmental motion fraction; Total disc replacement

Mesh:

Year:  2019        PMID: 31309331     DOI: 10.1007/s00586-019-06064-4

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  1 in total

1.  Local and global subaxial cervical spine biomechanics after single-level fusion or cervical arthroplasty.

Authors:  Michael A Finn; Darrel S Brodke; Michael Daubs; Alpesh Patel; Kent N Bachus
Journal:  Eur Spine J       Date:  2009-07-08       Impact factor: 3.134

  1 in total
  6 in total

1.  Total disc replacement alters the biomechanics of cervical spine based on sagittal cervical alignment: A finite element study.

Authors:  Muzammil Mumtaz; Justin Mendoza; Sudharshan Tripathi; Amey Kelkar; Norihiro Nishida; Ashish Sahai; Vijay K Goel
Journal:  J Craniovertebr Junction Spine       Date:  2022-09-14

2.  The MOVE-C Cervical Artificial Disc - Design, Materials, Mechanical Safety.

Authors:  Annette Kienle; Nicolas Graf; Carina Krais; Hans-Joachim Wilke
Journal:  Med Devices (Auckl)       Date:  2020-09-25

Review 3.  The Spine: A Strong, Stable, and Flexible Structure with Biomimetics Potential.

Authors:  Fabio Galbusera; Tito Bassani
Journal:  Biomimetics (Basel)       Date:  2019-08-30

4.  Comparison of 10-year Outcomes of Bryan Cervical Disc Arthroplasty for Myelopathy and Radiculopathy.

Authors:  Xiao Han; Da He; Ning Zhang; Qingpeng Song; Jinchao Wang; Wei Tian
Journal:  Orthop Surg       Date:  2019-11-25       Impact factor: 2.071

5.  Comparison of in vivo kinematic and radiological parameters of three cervical disc prostheses.

Authors:  Nicholas Chang; Ralph Mobbs; Nicholas Hui; Henry Lin
Journal:  J Craniovertebr Junction Spine       Date:  2022-03-09

6.  Catastrophic delayed cervical arthroplasty failure: illustrative case.

Authors:  Diego A Carrera; Christian B Ricks
Journal:  J Neurosurg Case Lessons       Date:  2022-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.